Amplify Weight Loss Drug & Treatment ETF (THNR)

25.05 -0.14 (-0.56%) USD  |  NYSEARCA  |  Nov 05, 11:30
More

THNR Monthly Value at Risk (VaR) 5% (Since Inception)

Monthly Value at Risk (VaR) 5% (Since Inception) Chart

View Monthly Value at Risk (VaR) 5% (Since Inception) for THNR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Monthly Value at Risk (VaR) 5% (Since Inception) Data

View and export this data back to 2024. Upgrade now.
Date Value
September 30, 2024 --
August 31, 2024 --
Date Value
July 31, 2024 --
June 30, 2024 --

Monthly Value at Risk (VaR) 5% (Since Inception) Range, Past 5 Years

Upgrade
Minimum
Jun 2024
Upgrade
Maximum
Sep 2024
Upgrade
Average
Upgrade
Median

Monthly Value at Risk (VaR) 5% (Since Inception) Benchmarks

WisdomTree BioRevolution ETF Upgrade
First Trust Nasdaq Lux Dgtl Hlth SoluETF Upgrade
Putnam BioRevolution ETF Upgrade
Global X Aging Population ETF Upgrade
Goldman Sachs Future Health Care Eq ETF Upgrade

Monthly Value at Risk (VaR) 5% (Since Inception) Related Metrics

Alpha (Since Inception) Upgrade
Beta (Since Inception) Upgrade
Alpha (vs YCharts Benchmark) (Since Inception) Upgrade
Beta (vs YCharts Benchmark) (Since Inception) Upgrade
Annualized Standard Deviation of Monthly Returns (Since Inception) Upgrade
Max Drawdown (Since Inception) Upgrade